| Title[sort] |
Cycle |
Award[sort] |
| Role of p68 in Breast Cancer |
2009 (Cycle 15) |
$165,335 |
| Investigator(s): Daojing Wang , Ph.D. |
15IB-0075 |
| The Regulation of SATB1 in Metastatic Breast Cancer |
2009 (Cycle 15) |
$36,379 |
| Investigator(s): Laurie Friesenhahn , Ph.D. |
15FB-0097 |
| Metabolite Imaging to Identify Drug Resistant Breast Cancer |
2009 (Cycle 15) |
$171,892 |
| Investigator(s): Trent Northen , Ph.D. |
15IB-0063 |
| Tumor Suppressor 14-3-3sigma in Breast Cancer Progression |
2008 (Cycle 14) |
$62,434 |
| Investigator(s): Aaron Boudreau , B.Sc. |
14GB-0007 |
| A Novel Epithelial-Stromal Model of Metastatic Breast Cancer |
2005 (Cycle 11) |
$205,716 |
| Investigator(s): Richard Neve , Ph.D. |
11IB-0154 |
| The Role of the ECM in Breast Cancer DNA Damage Repair |
2005 (Cycle 11) |
$250,560 |
| Investigator(s): Albert Davalos , Ph.D. |
11IB-0153 |
| Alternative pre-mRNA Splicing in Mammary Epithelial Cells |
2003 (Cycle IX) |
$119,968 |
| Investigator(s): John Conboy , Ph.D. |
9IB-0186 |
| Functional Analysis of BORIS, A Novel DNA-binding Protein |
2003 (Cycle IX) |
$92,426 |
| Investigator(s): Paul Yaswen , Ph.D. |
9WB-0193 |
| Studies of Telomere Capping Dysfunction in Breast Cancer |
2002 (Cycle VIII) |
$117,712 |
| Investigator(s): David Gilley , Ph.D. |
8KB-0119 |
| Effect of Breast Cell Environment on Repair of DNA Damage |
2002 (Cycle VIII) |
$80,656 |
| Investigator(s): Aylin Rizki , Ph.D. |
8FB-0184 |
| Does the BLM Gene Co-regulate BRCA1 in DNA Damage Response? |
2002 (Cycle VIII) |
$80,671 |
| Investigator(s): Albert Davalos , Ph.D. |
8FB-0148 |
| Three-Dimensional Modeling of Breast Cancer Progression |
2002 (Cycle VIII) |
$329,901 |
| Investigator(s): Carlos Ortiz de Solorzano , Ph.D. |
8WB-0150 |
| Global Gene Regulation by SATB1 in Metastatic Breast Cancer |
2002 (Cycle VIII) |
$161,176 |
| Investigator(s): Terumi Kohwi-Shigematsu , Ph.D. |
8IB-0183 |
| Statistical Techniques for Breast Biology & Cancer Research |
2002 (Cycle VIII) |
$792,845 |
| Investigator(s): Saira Mian , Ph.D. |
8PB-0171 |
| Understanding Aging Effects in the Breast |
2002 (Cycle VIII) |
$448,730 |
| Investigator(s): Ana Krtolica , Ph.D. |
8KB-0100 |
| Role of Epimorphin and Progesterone in Breast Development |
2002 (Cycle VIII) |
$23,713 |
| Investigator(s): Jamie Bascom , Ph.D. |
8GB-0147 |
| The Functions of BRCA2 in Repairing DNA Damage |
2001 (Cycle VII) |
$485,757 |
| Investigator(s): Yi-Ching Lio , Ph.D. |
7KB-0019 |
| Tumor Suppression by Dystroglycan in Breast Epithelial Cells |
2001 (Cycle VII) |
$9,624 |
| Investigator(s): John Muschler , Ph.D. |
7KB-0017 |
| Analysis of a Protease Involved in Mammary Development |
2001 (Cycle VII) |
$79,595 |
| Investigator(s): Rana Zahedi , Ph.D. |
7FB-0152 |
| Telomere Clustering is Lost in Mammary Epithelial Tumors |
2001 (Cycle VII) |
$79,999 |
| Investigator(s): Patrick Kaminker , Ph.D. |
7FB-0018 |
| Telomere Dynamics during Breast Development |
2001 (Cycle VII) |
$157,189 |
| Investigator(s): Sahn-Ho Kim , Ph.D. |
7KB-0151 |
| Cancer and Complexity: Questions for a New Millenium |
2000 (Cycle VI) |
$11,760 |
| Investigator(s): Mary Helen Barcellos-Hoff , Ph.D. |
6MB-0144 |
| Cancer and Complexity: Questions for a New Millenium |
2000 (Cycle VI) |
$11,760 |
| Investigator(s): G. Shyamala Harris , Ph.D. |
6MB-0144 |
| Cancer and Complexity: Questions for a New Millenium |
2000 (Cycle VI) |
$11,760 |
| Investigator(s): Mina Bissell , Ph.D. |
6MB-0144 |
| Role of MMPs in Breast Tumor Initiation and Aggressiveness |
2000 (Cycle VI) |
$75,422 |
| Investigator(s): Jimmie Fata , Ph.D. |
6FB-0131 |
| Immortalization of Human Mammary Epithelial Cells by ZNF217 |
2000 (Cycle VI) |
$249,255 |
| Investigator(s): Paul Yaswen , Ph.D. |
6JB-0133 |
| DNA Packaging Defects in Breast Cancer |
2000 (Cycle VI) |
$333,261 |
| Investigator(s): Terumi Kohwi-Shigematsu , Ph.D. |
6JB-0134 |
| Studies on the Role of the ER-beta in Breast Cancer |
2000 (Cycle VI) |
$59,102 |
| Investigator(s): Eli Gilad , Ph.D. |
6FB-0138 |
| Tumor Suppression by Dystrogylcan in Breast Epithelial Cells |
2000 (Cycle VI) |
$181,347 |
| Investigator(s): John Muschler , Ph.D. |
6KB-0130 |
| Role of p53 in Irradiated Stroma and Mammary Carcinogenesis |
2000 (Cycle VI) |
$335,335 |
| Investigator(s): Mary Helen Barcellos-Hoff , Ph.D. |
6JB-0132 |
| Hox Genes in Normal Breast Development and Breast Cancer |
1999 (Cycle V) |
$40,393 |
| Investigator(s): Carmen Hagios , Ph.D. |
5FB-0158 |
| Novel Binding Functions of Mutant p53 in Breast Cancer Cells |
1998 (Cycle IV) |
$68,889 |
| Investigator(s): Koji Itahana , Ph.D. |
4FB-0108 |
| Development of EGFR-Based Imaging Agents for Breast Cancer |
1998 (Cycle IV) |
$69,580 |
| Investigator(s): Henry VanBrocklin , Ph.D. |
4IB-0059 |
| Chromatin Regulation of Breast Cancer Cell Senescence |
1998 (Cycle IV) |
$231,844 |
| Investigator(s): Paul Kaufman , Ph.D. |
4JB-0089 |
| Genes Involved in Immortalization of Human Mammary Cells |
1998 (Cycle IV) |
$251,476 |
| Investigator(s): Martha Stampfer , Ph.D. |
4JB-0119 |
| Progesterone Receptor and Remodeling of Basement Membrane |
1998 (Cycle IV) |
$120,681 |
| Investigator(s): G. Shyamala Harris , Ph.D. |
4JB-0142 |
| TGF-Beta Receptor Signaling and Breast Cancer |
1998 (Cycle IV) |
$362,691 |
| Investigator(s): Kunxin Luo , Ph.D. |
4KB-0151 |
| Hormonal Regulation of TGF Beta During Mammary Development |
1998 (Cycle IV) |
$758,817 |
| Investigator(s): Mary Helen Barcellos-Hoff , Ph.D. |
4PB-0136 |
| Breast Carcinoma Associated MAR-binding Proteins p90 and p70 |
1997 (Cycle III) |
$69,998 |
| Investigator(s): Sanjeev Galande , Ph.D. |
3FB-0053 |
| ECM-Regulated Transcription in Breast Cancer |
1997 (Cycle III) |
$62,776 |
| Investigator(s): Philippe Pujuguet , Ph.D. |
3FB-0055 |
| Characterization of Heregulin Targeted Genes |
1997 (Cycle III) |
$22,115 |
| Investigator(s): Fabiana Guerra-Vladusic , Ph.D. |
3FB-0116 |
| Fate Mapping of Progesterone Receptor Positive Breast Cells |
1997 (Cycle III) |
$243,380 |
| Investigator(s): G. Shyamala Harris , Ph.D. |
3IB-0034 |
| Does Cell Aging Cause Breast Cancer? |
1997 (Cycle III) |
$239,303 |
| Investigator(s): Judith Campisi , Ph.D. |
3IB-0036 |
| The Role of a Novel Estrogen Receptor in Breast Cancer |
1997 (Cycle III) |
$231,039 |
| Investigator(s): Ruth Lupu , Ph.D. |
3IB-0118 |
| Loss of Tumor Suppressor Proteins in Breast Cancer Cells |
1996 (Cycle II) |
$69,605 |
| Investigator(s): Sahn-Ho Kim , Ph.D. |
2FB-0226 |
| Targeted search for new transcription factors in breast cell |
1996 (Cycle II) |
$61,231 |
| Investigator(s): Claudia Lin , Ph.D. |
2FB-0235 |
| Identification of new candidate breast cancer genes |
1996 (Cycle II) |
$135,748 |
| Investigator(s): Donna Albertson , Ph.D. |
2RB-0225 |
| Cell Microenvironment and Progression of Breast Cancer |
1995 (Cycle I) |
$66,048 |
| Investigator(s): Andre Lochter , Ph.D. |
1FB-0391 |
| Vitamin D and Breast Cancer Prevention: Cell Death vs Growth |
1995 (Cycle I) |
$70,000 |
| Investigator(s): Valerie Weaver , Ph.D. |
1FB-0400 |
| New Method for Measuring Breast Cancer Gene Expression |
1995 (Cycle I) |
$85,706 |
| Investigator(s): Daniel Pinkel , Ph.D. |
1IB-0003 |
| Progesterone Action in Human Breast Cancer |
1995 (Cycle I) |
$85,733 |
| Investigator(s): G. Shyamala Harris , Ph.D. |
1IB-0448 |
| The Invasive Nature of Epithelial Breast Cancer Cells |
1995 (Cycle I) |
$105,837 |
| Investigator(s): Pierre-Yves Desprez , Ph.D. |
1KB-0274 |
| Novel PET cameras for Earlier Detection of Breast Cancer |
1995 (Cycle I) |
$446,093 |
| Investigator(s): William Moses , Ph.D. |
1RB-0068 |
| The Role of MAR-Binding Protein in Breast Cancer |
1995 (Cycle I) |
$328,849 |
| Investigator(s): Terumi Kohwi-Shigematsu , Ph.D. |
1RB-0381A |
| Metabolism of Environmental Chemicals as Breast Cancer Risk |
1995 (Cycle I) |
$272,029 |
| Investigator(s): Regine Goth-Goldstein , Ph.D. |
1RB-0429 |
